Transporters | Cyprotex

The Role of BSEP/MRP Transporter Interactions in Cholestatic Drug-induced Liver Injury

With the advent of more complex drug therapies and combinations, drug-induced liver injury (DILI) is becoming more […]

Knowledge sharing is a key corporate responsibility for Cyprotex, and helps us to share our expertise with […]

It’s been quite a journey over the past 20 years! In this blog, we travel down memory […]

The most important OATP family member expressed in the human liver is OATP1B1, responsible for hepatic uptake […]

Drug-drug interactions (DDIs) can often be a complex mix of multiple mechanisms – therefore understanding the impact […]